NASDAQ: LEGN
Legend Biotech Corp Stock Ownership - Who owns Legend Biotech?

Insider buying vs selling

Have Legend Biotech Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ying HuangChief Executive Officer2026-03-259,936$8.77
$87.14kSell

1 of 1

LEGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LEGN insiders and whales buy or sell their stock.

LEGN Shareholders

What type of owners hold Legend Biotech Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC6.56%24,268,223$552.59MInstitution
Suvretta Capital Management LLC1.79%6,608,629$150.48MInstitution
Westfield Capital Management Co LP1.67%6,164,677$140.37MInstitution
Hhlr Advisors Ltd1.62%5,984,550$136.27MInstitution
Deerfield Management Company LP1.60%5,932,000$135.07MInstitution
Blackrock Inc1.16%4,276,913$97.39MInstitution
Point72 Asset Management LP0.75%2,784,806$63.41MInstitution
Artisan Partners Limited Partnership0.63%2,341,074$53.31MInstitution
Goldman Sachs Group Inc 10.59%2,174,535$49.51MInstitution
Goldman Sachs Group Inc0.59%2,174,535$49.51MInstitution

1 of 3

LEGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LEGN23.68%0.15%Net SellingNet Selling
KNSA55.85%9.27%Net SellingNet Selling
LGND18.32%81.68%Net SellingNet Selling
CRNX89.57%10.43%Net SellingNet Selling
XENE97.13%2.87%Net SellingNet Selling

Legend Biotech Stock Ownership FAQ

Who owns Legend Biotech?

Legend Biotech (NASDAQ: LEGN) is owned by 23.68% institutional shareholders, 0.15% Legend Biotech insiders, and 76.17% retail investors. Fmr LLC is the largest individual Legend Biotech shareholder, owning 24.27M shares representing 6.56% of the company. Fmr LLC's Legend Biotech shares are currently valued at $570.79M.

If you're new to stock investing, here's how to buy Legend Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.